PARTNERSHIP POSSIBILITIES BETWEEN PHARMACEUTICAL AND COSMETIC COMPANIES AND FONDATION RENE TOURAINE
98 fellowships have been awarded since 1993 to researchers coming from 25 countries, summing up to a granted amount of 576 000 €. From 2011 onwards, the fellowship awardees will be an-nounced each year at the ESDR René Touraine Lecture.
The name of your company could be associated with one or several of these fellowships (the Fonda-tion René Touraine grants at present 1 fellowship of 18 000 € and 4 fellowships of 4 500 €).
Since 1993, the Fondation René Touraine organises an annual top-level symposium on a different skin cell, presenting the state of the art on its physiology, pathophysiology and pharmacological modulation. The 20th meeting in 2012 will be on « Cutaneous dendritic cells ».
This top-level yealy symposium can be the occasion for a pharceutical or cosmetic industry to:
1. meet the leaders in the field,
2. to organise a press conference presenting the symposium highlights and the research strategy of your company.
The Fondation René Touraine has set up in 2002 a worldwide directory of leading experts in dermatology, listing for each physician their main topics of interest. This directory has become the official directory of the International League of Dermatological Societies (ILDS).
The “Who and How” directory is a unique opportunity for your teams in different countries to meet the local experts and hence update the directory through an action valuing those experts.
The Fondation René Touraine has created the Psoriasis International Network (PIN) in 2005, as a joint action with the EADV Psoriasis Task Force. This network gathers some 4000 dermatologists from 80 countries, as well as patient associations. PIN fosters the development of thematic consultations on psoriasis in each dermatology department, and organises every 3 years an international congress on psoriasis. This congress has become the main psoriasis congress in the world with almost 1500 participants in 2010.
Thanks to the Foundation’s Scientific Board, this network will become a platform for projects of therapeutic and clinical research, to which interested pharmaceutical companies can be associated. Some of our Founders have already helped in the creation of regional networks on psoriasis.
Thérapeutique Dermatologique, reference book on the management of skin diseases in French-speaking countries (1288 pages and 333 authors) is available for free on the web since 2005. This website receives 1 million visits a year. The visitors come from 137 countries. The website is going to be translated into English and will become an international platform for exchanging on the different strategies for the management of skin diseases.
This platform will have 2 types of access:
• An access for the patients and the general public, which will include medical information and electronic resources, adapted for the education of patients and their families.
• A private access for health professionals, which will be open to publicity by means of an annual contract comprising different services.
This website will work as a permanent congress and will be open to the opinion of leading experts on therapeutic strategies, which you know can greatly differ from one region to another.
We hope that in 3-years time, when the whole book will be translated into English, the website will reach over 10 million visits/prescriber/year.
Since 2003, the action « Genodermatoses in Mediterranean - Together Against Genodermatoses » is being developed at the European and the Mediterranean level within the framework of rare dis-eases. The Fondation René Touraine has been designated as an expert to the European Union Committee of Experts on Rare Diseases (EUCERD). This action gathers European, Mediterranean and Middle-Eastern countries in order to find the means to improve the access to health care by pa-tients suffering from severe genodermatoses. This implies the creation of dedicated consultations in each dermatology department, then to network these consultations, and to improve the access of patients to the medication they need. An inventory is undergoing in each country participating to this action in order to list the medicines and medical devices available and needed, which will lead to ne-gotiations between pharmaceutical and cosmetic industries and the health authorities of each country.
The Foundation has been able to develop this action thanks to the support of one of its founding members, the laboratories Pierre Fabre, and from 2008 to 2011 thanks to the support of a European Union grant.
This action might interest those industries willing to get involved in the health care of rare diseases.
The Fondation René Touraine is officially recognised of public utility by the French government. According to the French law, this status gives right to a tax deduction of 60 % of the donation amount within a limit of 5 per 1000 of the company’s turnover, with the possibility of carrying forward over 5 years in case of deficit.
